Vertex challenger Sionna prices $191M IPO
Bio Pharma Dive
FEBRUARY 6, 2025
The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or be used in new, multi-drug combinations.
Thu.Feb 06, 2025
287 
Grand Rounds January 31, 2025: Advancing Rural Back Pain Outcomes Using Rehabilitation Telehealth (ARBOR-Telehealth): Early Progress and Lessons Learned (Richard L. Skolasky, ScD; Kevin H. McLaughlin, DPT)
Rethinking Clinical Trials
FEBRUARY 6, 2025
Speakers Richard L. Skolasky, ScD Professor, Johns Hopkins School of Medicine Department of Orthopaedic Surgery Kevin H. McLaughlin, DPT Assistant Professor, Johns Hopkins School of Medicine Department of Physical Medicine and Rehabilitation Slides Keywords Back Pain; Rural Health; Telehealth Key Points Low back pain (LBP) is the most common cause of disability globally and in the U.S.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bristol Myers gives first peek at closely watched launch of schizophrenia drug
Bio Pharma Dive
FEBRUARY 6, 2025
Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and is around 1,000 prescriptions weekly by late January.
Revealed: How Much Exercise You Need to ‘Offset’ a Day of Sitting
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 6, 2025
(Jack Atkinson/Unsplash) We know that spending lots of time sitting down isn’t good for us, but just how much exercise is needed to counteract the negative health effects of sitting down all day? Research suggests about 30-40 minutes per day of building up a sweat should do it.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bristol Myers, bracing for key patent losses, deepens cost-cutting plan
Bio Pharma Dive
FEBRUARY 6, 2025
The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies across multiple areas of the business,” its CFO told analysts on a conference call.
Novo Nordisk plans new study for CagriSema, targets 2026 submission
Pharmaceutical Technology
FEBRUARY 6, 2025
CagriSema, considered a successor to Wegovy, is Novo Nordisks most likely route of gaining GLP-1RA market share back from Eli Lilly.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
AstraZeneca’s shares rise as it addresses China investigation
Pharmaceutical Technology
FEBRUARY 6, 2025
The UK-based drugmaker reported a 21% increase in annual revenues, reaching 43bn ($54.1bn) in 2024.
Pfizer taps a former Novartis exec to lead cancer drug push
Bio Pharma Dive
FEBRUARY 6, 2025
The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow sales in the years ahead.
FDA grants orphan drug status to Arbor Biotechnologies’ PH1
Pharmaceutical Technology
FEBRUARY 6, 2025
The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria type 1 (PH1).
FDA grants Orphan Drug Designation to Ariceum cancer therapy
Pharma Times
FEBRUARY 6, 2025
Designation follows promising preclinical data and FDA clearance
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Tripartite MoU signed for mRNA production platform in Egypt
Pharmaceutical Technology
FEBRUARY 6, 2025
EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.
BMS extends its cost-cutting drive by another $2bn
pharmaphorum
FEBRUARY 6, 2025
BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2,200 job cuts, adding a target of another $2bn by end-2027.
Supernus wins FDA approval for Parkinson’s pump on fourth try
Pharmaceutical Technology
FEBRUARY 6, 2025
The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.
Qureight and Avalyn launch strategic partnership in pulmonary fibrosis
Pharma Times
FEBRUARY 6, 2025
Partnership aims to leverage cutting-edge technology in clinical trials
USPTO grants patent to Vistagen’s neuropathic pain treatment
Pharmaceutical Technology
FEBRUARY 6, 2025
The USPTO has granted a patent to Vistagens non-opioid oral product candidate AV-101 for neuropathic pain treatment.
Novo charts course ahead for CagriSema after lacklustre data
pharmaphorum
FEBRUARY 6, 2025
After its first phase 3 trial of obesity hope CagriSema left investors dissatisfied, Novo Nordisk has a plan to get the programme back on track.
Help for HRPPs: Educating the New Researcher community on SBER Basics
Advarra
FEBRUARY 6, 2025
The beginning of a new semester brings a fresh crop of aspiring researchers to institutions each fall and spring. Students learn how to navigate post-secondary education and gain knowledge around effective research methods, both practical and intangible. Student researchers, along with early career researchers (collectively referred to here as new researchers), begin to experience responsible conduct of research principles firsthand.
Clinical trends for 2025: A year of change
pharmaphorum
FEBRUARY 6, 2025
Explore the clinical trends expected for 2025 - including ADCs, Radiopharmaceuticals, CGTs, AAV, and rare diseases. Stay ahead of the curve with these industry insights.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
How to Get a Pharmacy Job in Australia with the OPRA Exam?
Pharma Tutor
FEBRUARY 6, 2025
How to Get a Pharmacy Job in Australia with the OPRA Exam? admin Thu, 02/06/2025 - 16:25 Overseas Pharmacist Readiness Assessment, or the OPRA exam, is a single-paper test conducted by the Australian Pharmacy Council. This is a part of the skills assessment process by the APC, which aims to test the competency of global pharmacists before offering them registration in Australia.
Pressure relieved on AZ as details of Chinese probe emerge
pharmaphorum
FEBRUARY 6, 2025
AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.
Rebates or Patients?
Pharmaceutical Commerce
FEBRUARY 6, 2025
Finding the optimal balance in pharmacy benefit manager reform.
Insights from JP Morgan 2025: Key trends shaping the pharma industry
pharmaphorum
FEBRUARY 6, 2025
Tune in to the latest insights from JP Morgan Healthcare 2025 in this exclusive podcast interview, exploring key trends shaping the pharmaceutical industry. Stay informed and ahead of the curve.
Closing the Health Literacy and Diversity Gaps in Clinical Trials
Pharmaceutical Commerce
FEBRUARY 6, 2025
New engagement approaches can help drive treatment gains in underrepresented communities.
7th Neuroimmunology Drug Development Summit
pharmaphorum
FEBRUARY 6, 2025
The 7th Neuroimmunology Drug Development Summit, organised by Hanson Wade, is a premier event bringing together experts in the field to discuss the latest advancements and challenges in neuroimmunology drug development. Find out more about this must-attend event.
Popping the Gross-to-Net Bubble, Part II: What Manufacturers Can Do About It
Pharmaceutical Commerce
FEBRUARY 6, 2025
A look at the actionable steps needed to elicit change.
NICE contribution to the cost per QALY threshold debate?
pharmaphorum
FEBRUARY 6, 2025
NICE, the National Institute for Health and Care Excellence, plays a significant role in the cost per Quality-Adjusted Life Year (QALY) threshold debate. Learn more about NICE's contributions and impact.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Further Exploration of Employer Benefits
Pharmaceutical Commerce
FEBRUARY 6, 2025
A survey study of US employers aims to determine whether they prioritize financial or nonfinancial criteria when selecting health plans.
Paving the road to functionally active antibody drugs
pharmaphorum
FEBRUARY 6, 2025
Explore how advancements in antibody drugs are paving the way for targeted treatments of autoimmune diseases. Learn how these therapies are revolutionising the field.
Pharma Pulse 2/6/25: The Blue Jacket Fashion Show, Gold Bagging & more
Pharmaceutical Commerce
FEBRUARY 6, 2025
The latest news for pharma industry insiders.
Newel's VR therapy for chronic pain nears EU market
pharmaphorum
FEBRUARY 6, 2025
Newel Health has been granted EU certification for its VR-based digital therapeutic for chronic pain, clearing the way for its launch in Europe.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content